Q4 2025 earnings call recap: sales growth, margin outlook, 2026 guidance, buybacks & dividend hike, plus key wins—read now.
C Energy has completed laboratory validation of its proprietary geothermal reservoir stimulation technology in superhot ...
TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...
Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...
Updated PEA Copper Fox has commissioned Moose Mountain Technical Services to prepare an updated PEA on the Van Dyke copper project in accordance with the Canadian disclosure requirements of National ...
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Looking to navigate the AI startup space? Start by focusing on defensible technology and regulatory foundations, rather than simply building interfaces on existing platforms, say experts at a recent ...
PHINIA Inc. , a leader in premium fuel systems, electrical systems, and aftermarket solutions, today reported results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results